A representative member of the amino‐imidazolin‐2‐imine ligand class (HAmIm) is studied as a strong monoanionic N , N ′‐chelating ligand in zinc(I) and zinc(II) complexes. The Brønsted‐basic zinc precursors ZnH 2 , ZnEt 2 , and [Zn 2 ( η 5 ‐C 5 Me 5 ) 2 ] undergo in situ deprotonation with HAmIm, accompanied by the formation of only volatile side products (H 2 , C 2 H 6 , C 5 Me 5 H). Under these mild conditions, both Zn(II) complexes [(AmIm)ZnH] 2 and [(AmIm)ZnEt], as well as the more sensitive Zn(I) complexes [( η 5 ‐C 5 Me 5 )Zn 2 (AmIm)] and [Zn 2 (AmIm) 2 ] with a covalent ZnZn bond, are obtained in high purity. In comparison to related β‐diketimine ligands (HNacNac), the amino‐imidazolin‐2‐imine (HAmIm) proves to be more controllable in its reactivity toward zinc precursors.
No takes yet. Share an insight, caveat, or question.
Wessel et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: